pargyline has been researched along with cardiovascular agents in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Papadopoulos, C | 1 |
| HARRIS, JE | 1 |
2 other study(ies) available for pargyline and cardiovascular agents
| Article | Year |
|---|---|
Cardiovascular drugs and sexuality: a cardiologist's review.
Topics: Cardiovascular Agents; Digitalis Glycosides; Disopyramide; Diuretics; Female; Humans; Hypolipidemic Agents; Male; Pargyline; Sexual Dysfunction, Physiological; Sympatholytics; Vasodilator Agents | 1980 |
CARDIOVASCULAR RENAL AGENTS AS THEY IMPINGE ON OPHTHALMIC PRACTICE.
Topics: Antihypertensive Agents; Benzothiadiazines; Bretylium Compounds; Carbonic Anhydrase Inhibitors; Cardiovascular Agents; Diuretics; Drug Therapy; Glycerol; Guanethidine; Hexamethonium Compounds; Hydralazine; Mannitol; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Ophthalmology; Organomercury Compounds; Pargyline; Pentolinium Tartrate; Renal Agents; Reserpine; Tetraethylammonium Compounds; Toxicology; Urea; Veratrum; Veratrum Alkaloids | 1964 |